GreenGene F在美治疗A型血友病进入3期临床试验

2012-04-16 环球医学环球医学

2012年2月28日，美国FDA批准韩国生物制药公司绿十字公司的IND申请，该IND申请是关于启动一项重组VIII因子产品GreenGene F(Berotocog alfa)在美国治疗A型血友病的3期临床试验。 GreenGene F是一种重组人B区缺失凝血因子VIII，目前正由绿十字公司开发。理化分析显示，GreenGene F的同质性得到了改善且杂质水平较低。此外，制造过程中采用无血清和白

2012年2月28日，美国FDA批准韩国生物制药公司绿十字公司的IND申请，该IND申请是关于启动一项重组VIII因子产品GreenGene F(Berotocog alfa)在美国治疗A型血友病的3期临床试验。

GreenGene F是一种重组人B区缺失凝血因子VIII，目前正由绿十字公司开发。理化分析显示，GreenGene F的同质性得到了改善且杂质水平较低。此外，制造过程中采用无血清和白蛋白培养方式，再加上两道病原体灭活工序，并用一种专利的氨基酸组成替代白蛋白来稳定最终的结构。

绿十字说：“GreenGene F是第三代重组凝血因子VIII，其所携带的感染风险极小，并已于2010年获韩国食品和药物管理局(KFDA)批准后在韩国上市。有了这项临床研究，我们就有望将GreenGene F的市场扩大到其他国家，我们预计，随着其安全性得到改善，GreenGene F将为A型血友病患者提供更多的选择。”（生物谷 Bioon.com）

>>延伸阅读：Science：基因研究证明“皇家病”是B型血友病

>>延伸阅读：NEJM：基因疗法治疗血友病获初步成功

>>延伸阅读：Blood：血管性血友病因子(VWF)功能的新调控机制

>>延伸阅读：E．Eng．Jou．：基因治疗可用于B型血友病

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1678119, encodeId=d50316e81193b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Sep 02 08:51:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048431, encodeId=ffeb204843105, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 22:51:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911211, encodeId=42481911211b8, content=<a href='/topic/show?id=18171289d6' target=_blank style='color:#2F92EE;'>#3期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1289, encryptionId=18171289d6, topicName=3期临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Mar 18 22:51:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081317, encodeId=d60d208131e91, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6785, encryptionId=57406e8506, topicName=Eng)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue Dec 25 19:51:00 CST 2012, time=2012-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264114, encodeId=eec912641142b, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595496, encodeId=621e1595496aa, content=<a href='/topic/show?id=371912932d' target=_blank style='color:#2F92EE;'>#3期临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1293, encryptionId=371912932d, topicName=3期临床试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
2012-09-02 仁者大医

#A型血#

67 0
[GetPortalCommentsPageByObjectIdResponse(id=1678119, encodeId=d50316e81193b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Sep 02 08:51:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048431, encodeId=ffeb204843105, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 22:51:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911211, encodeId=42481911211b8, content=<a href='/topic/show?id=18171289d6' target=_blank style='color:#2F92EE;'>#3期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1289, encryptionId=18171289d6, topicName=3期临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Mar 18 22:51:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081317, encodeId=d60d208131e91, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6785, encryptionId=57406e8506, topicName=Eng)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue Dec 25 19:51:00 CST 2012, time=2012-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264114, encodeId=eec912641142b, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595496, encodeId=621e1595496aa, content=<a href='/topic/show?id=371912932d' target=_blank style='color:#2F92EE;'>#3期临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1293, encryptionId=371912932d, topicName=3期临床试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
2012-08-02 cy0324

#Gene#

46 0
[GetPortalCommentsPageByObjectIdResponse(id=1678119, encodeId=d50316e81193b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Sep 02 08:51:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048431, encodeId=ffeb204843105, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 22:51:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911211, encodeId=42481911211b8, content=<a href='/topic/show?id=18171289d6' target=_blank style='color:#2F92EE;'>#3期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1289, encryptionId=18171289d6, topicName=3期临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Mar 18 22:51:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081317, encodeId=d60d208131e91, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6785, encryptionId=57406e8506, topicName=Eng)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue Dec 25 19:51:00 CST 2012, time=2012-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264114, encodeId=eec912641142b, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595496, encodeId=621e1595496aa, content=<a href='/topic/show?id=371912932d' target=_blank style='color:#2F92EE;'>#3期临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1293, encryptionId=371912932d, topicName=3期临床试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
2013-03-18 andy2087

#3期临床#

57 0
[GetPortalCommentsPageByObjectIdResponse(id=1678119, encodeId=d50316e81193b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Sep 02 08:51:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048431, encodeId=ffeb204843105, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 22:51:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911211, encodeId=42481911211b8, content=<a href='/topic/show?id=18171289d6' target=_blank style='color:#2F92EE;'>#3期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1289, encryptionId=18171289d6, topicName=3期临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Mar 18 22:51:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081317, encodeId=d60d208131e91, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6785, encryptionId=57406e8506, topicName=Eng)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue Dec 25 19:51:00 CST 2012, time=2012-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264114, encodeId=eec912641142b, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595496, encodeId=621e1595496aa, content=<a href='/topic/show?id=371912932d' target=_blank style='color:#2F92EE;'>#3期临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1293, encryptionId=371912932d, topicName=3期临床试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
2012-12-25 spoonycyy

#Eng#

55 0
[GetPortalCommentsPageByObjectIdResponse(id=1678119, encodeId=d50316e81193b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Sep 02 08:51:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048431, encodeId=ffeb204843105, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 22:51:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911211, encodeId=42481911211b8, content=<a href='/topic/show?id=18171289d6' target=_blank style='color:#2F92EE;'>#3期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1289, encryptionId=18171289d6, topicName=3期临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Mar 18 22:51:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081317, encodeId=d60d208131e91, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6785, encryptionId=57406e8506, topicName=Eng)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue Dec 25 19:51:00 CST 2012, time=2012-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264114, encodeId=eec912641142b, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595496, encodeId=621e1595496aa, content=<a href='/topic/show?id=371912932d' target=_blank style='color:#2F92EE;'>#3期临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1293, encryptionId=371912932d, topicName=3期临床试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
2012-04-18 changfy

#A型血友病#

58 0
[GetPortalCommentsPageByObjectIdResponse(id=1678119, encodeId=d50316e81193b, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Sep 02 08:51:00 CST 2012, time=2012-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048431, encodeId=ffeb204843105, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Aug 02 22:51:00 CST 2012, time=2012-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911211, encodeId=42481911211b8, content=<a href='/topic/show?id=18171289d6' target=_blank style='color:#2F92EE;'>#3期临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1289, encryptionId=18171289d6, topicName=3期临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d275294, createdName=andy2087, createdTime=Mon Mar 18 22:51:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2081317, encodeId=d60d208131e91, content=<a href='/topic/show?id=57406e8506' target=_blank style='color:#2F92EE;'>#Eng#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6785, encryptionId=57406e8506, topicName=Eng)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Tue Dec 25 19:51:00 CST 2012, time=2012-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264114, encodeId=eec912641142b, content=<a href='/topic/show?id=ffb03111a1' target=_blank style='color:#2F92EE;'>#A型血友病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3111, encryptionId=ffb03111a1, topicName=A型血友病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595496, encodeId=621e1595496aa, content=<a href='/topic/show?id=371912932d' target=_blank style='color:#2F92EE;'>#3期临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1293, encryptionId=371912932d, topicName=3期临床试验)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 18 11:51:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
2012-04-18 仁医06

#3期临床试验#

52 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

药械

GreenGene F在美治疗A型血友病进入3期临床试验

相关资讯

科室

工具

服务